These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 28296677)

  • 41. Xp11.2 translocation renal cell carcinoma with PSF-TFE3 rearrangement.
    Zhong M; Weisman P; Zhu B; Brassesco M; Yang Y; Linehan WM; Merino MJ; Zhang D; Rohan S; Cai D; Yang X
    Diagn Mol Pathol; 2013 Jun; 22(2):107-11. PubMed ID: 23628822
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dual-color, break-apart FISH assay on paraffin-embedded tissues as an adjunct to diagnosis of Xp11 translocation renal cell carcinoma and alveolar soft part sarcoma.
    Zhong M; De Angelo P; Osborne L; Keane-Tarchichi M; Goldfischer M; Edelmann L; Yang Y; Linehan WM; Merino MJ; Aisner S; Hameed M
    Am J Surg Pathol; 2010 Jun; 34(6):757-66. PubMed ID: 20421778
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cytologic Features of Renal Carcinoma Associated with Xp11.2 Translocations/ TFE3 Gene Fusions: A Case Report with Voided and Catheterized Urine Cytology and a Literature Review.
    Kuwamoto S; Murai Y; Endo Y; Masago T; Kuroda N; Horie Y
    Acta Cytol; 2014; 58(4):406-12. PubMed ID: 25227872
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnostic pitfall on the histological spectrum of adult-onset renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.
    Kuroda N; Katto K; Tanaka Y; Yamaguchi T; Inoue K; Ohara M; Mizuno K; Hes O; Michal M; Lee GH
    Med Mol Morphol; 2010 Jun; 43(2):86-90. PubMed ID: 20683695
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The suitability of NONO-TFE3 dual-fusion FISH assay as a diagnostic tool for NONO-TFE3 renal cell carcinoma.
    Liu N; Guo W; Shi Q; Zhuang W; Pu X; Chen S; Qu F; Xu L; Zhao X; Li X; Zhang G; Guo H; Gan W; Li D
    Sci Rep; 2020 Oct; 10(1):16361. PubMed ID: 33004995
    [TBL] [Abstract][Full Text] [Related]  

  • 46. NEAT1-TFE3 and KAT6A-TFE3 renal cell carcinomas, new members of MiT family translocation renal cell carcinoma.
    Pei J; Cooper H; Flieder DB; Talarchek JN; Al-Saleem T; Uzzo RG; Dulaimi E; Patchefsky AS; Testa JR; Wei S
    Mod Pathol; 2019 May; 32(5):710-716. PubMed ID: 30622287
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A novel VCP::TFE3 gene fusion resulting from t(X;9)(p11.23;p13.3) chromosome translocation in TFE3 rearranged renal cancer cell carcinoma.
    Kuentz MA; Blons H; Gimenez-Roqueplo AP; Just PA; Laurent-Puig P; Mejean A; Oudard S; Verkarre V
    Genes Chromosomes Cancer; 2023 Jun; 62(6):361-366. PubMed ID: 36695651
    [TBL] [Abstract][Full Text] [Related]  

  • 48. TFE3 translocation and protein expression in renal cell carcinoma are correlated with poor prognosis.
    Lee HJ; Shin DH; Kim SY; Hwang CS; Lee JH; Park WY; Choi KU; Kim JY; Lee CH; Sol MY; Rha SH; Park SW
    Histopathology; 2018 Nov; 73(5):758-766. PubMed ID: 29968390
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Rare Partner of TFE3 in the Xp11 Translocation Renal Cell Carcinoma: Clinicopathological Analyses and Detection of MED15-TFE3 Fusion.
    Ye H; Qin S; Li N; Lin M; Xu Y; Li X
    Biomed Res Int; 2019; 2019():5974089. PubMed ID: 31828108
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adult-onset renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusion with smooth muscle stroma and abnormal vessels.
    Kuroda N; Tamura M; Tanaka Y; Hes O; Michal M; Inoue K; Ohara M; Mizuno K; Lee GH
    Pathol Int; 2009 Jul; 59(7):486-91. PubMed ID: 19563413
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Altered expression of key cell cycle regulators in renal cell carcinoma associated with Xp11.2 translocation.
    Barroca H; Castedo S; Vieira J; Teixeira M; Müller-Höcker J
    Pathol Res Pract; 2009; 205(7):466-72. PubMed ID: 19246164
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Renal cell carcinoma associated with transcription factor E3 expression and Xp11.2 translocation: incidence, characteristics, and prognosis.
    Klatte T; Streubel B; Wrba F; Remzi M; Krammer B; de Martino M; Waldert M; Marberger M; Susani M; Haitel A
    Am J Clin Pathol; 2012 May; 137(5):761-8. PubMed ID: 22523215
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pediatric renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions and clinicopathologic associations.
    Altinok G; Kattar MM; Mohamed A; Poulik J; Grignon D; Rabah R
    Pediatr Dev Pathol; 2005; 8(2):168-80. PubMed ID: 15747097
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusions: clinical experience and literature review.
    He J; Chen X; Gan W; Zhu B; Fan X; Guo H; Jia R
    Future Oncol; 2015; 11(24):3243-52. PubMed ID: 26169997
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Xp11 translocation renal cell carcinoma with morphological features mimicking multilocular cystic renal neoplasm of low malignant potential: a series of six cases with molecular analysis.
    Song Y; Yin X; Xia Q; Zheng L; Yao J; Zeng H; Nie L; Gong J; Zhou Q; Chen N
    J Clin Pathol; 2021 Mar; 74(3):171-176. PubMed ID: 32699116
    [TBL] [Abstract][Full Text] [Related]  

  • 56. XP11.2 translocation renal cell carcinoma: clinical experience of Taipei Veterans General Hospital.
    Hung CC; Pan CC; Lin CC; Lin AT; Chen KK; Chang YH
    J Chin Med Assoc; 2011 Nov; 74(11):500-4. PubMed ID: 22100019
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pseudocapsule of renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion: a clue for tumor enucleation?
    Cheng X; He J; Gan W; Fan X; Yang J; Zhu B; Guo H
    Int J Clin Exp Pathol; 2015; 8(5):5403-10. PubMed ID: 26191243
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cathepsin-K immunoreactivity distinguishes MiTF/TFE family renal translocation carcinomas from other renal carcinomas.
    Martignoni G; Pea M; Gobbo S; Brunelli M; Bonetti F; Segala D; Pan CC; Netto G; Doglioni C; Hes O; Argani P; Chilosi M
    Mod Pathol; 2009 Aug; 22(8):1016-22. PubMed ID: 19396149
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Renal cancer associated with Xp11.2 translocation/TFE3 gene fusion: Clinicopathological analysis of 13 cases.
    Feng R; Tao Y; Chen Y; Xu W; Zhang G; Wang H
    Ann Diagn Pathol; 2022 Jun; 58():151908. PubMed ID: 35149286
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular-genetic analysis is essential for accurate classification of renal carcinoma resembling Xp11.2 translocation carcinoma.
    Hayes M; Peckova K; Martinek P; Hora M; Kalusova K; Straka L; Daum O; Kokoskova B; Rotterova P; Pivovarčikova K; Branzovsky J; Dubova M; Vesela P; Michal M; Hes O
    Virchows Arch; 2015 Mar; 466(3):313-22. PubMed ID: 25544614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.